scholarly journals Cost‐effectiveness analysis of low‐dose direct oral anticoagulant (DOAC) for the prevention of cancer‐associated thrombosis in the United States

Cancer ◽  
2020 ◽  
Vol 126 (8) ◽  
pp. 1736-1748 ◽  
Author(s):  
Ang Li ◽  
Josh J. Carlson ◽  
Nicole M. Kuderer ◽  
Jordan K. Schaefer ◽  
Shan Li ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Oral Anticoagulant ◽  
Low Dose ◽  
The United States ◽  
Cost Effectiveness Analysis ◽  
Direct Oral Anticoagulant ◽  
Effectiveness Analysis ◽  
Prevention Of Cancer ◽  
Cancer Associated Thrombosis
Sign in / Sign up

Export Citation Format

Share Document